Souhaitez-vous accéder aux communiqués récents ?

Dublin, Sept. 23, 2025 (GLOBE NEWSWIRE) -- The "AI & ML in Clinical Trials: Fundamentals, Applications, and Regulatory Aspects Training Course (Nov 6th, 2025)" has been added to ...

Kensana Health secures $120M from GEM to advance AI-driven plant-based medicines, with lead drug KV23a and plans for NASDAQ listing in Q2 2026.

SYDNEY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces the successful conduct of its scheduled Type C meeting (written response) on Alzheimer’s disease (AD) with...

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "High-Grade Glioma - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an...

Dublin, Sept. 10, 2025 (GLOBE NEWSWIRE) -- The "Peptide Cancer Vaccine Market Opportunity, Technology Platforms & Clinical Trials Insight 2030" report has been added to ResearchAndMarkets.com's...

PharmAla announces completion of onboarding for its US distribution centre and resignation of its Chief Operating Officer.

Dublin, Sept. 04, 2025 (GLOBE NEWSWIRE) -- The "Software Automation in Research and Development (R&D) Clinical Trials Training Course (Oct 1, 2025)" training has been added to ...

Science 37 and Catalent announce a strategic partnership enabling direct-to-patient investigational medicinal product (IMP) delivery for clinical research.

Industry veterans David R. Epstein and Michael A. Margolis have been appointed as members of Cancer Focus Fund's Investment Committee Advisory Board.

ProductLife Group (PLG) is proud to announce the opening of its newest office in Japan.